Partner
Pierre Beauparlant
Venture Partner, Sanderling Ventures
- Firm
- Sanderling Ventures
- Title
- Venture Partner
- Role
- Venture partner
- Known as
- Investor
Claim, correct or request removal
Record updated 21 September 2026
About
Pierre Beauparlant, Ph.D, has more than 25 years of experience in large pharma and development stage, venture backed biopharmaceutical companies with expertise from discovery through commercialization. Dr. Beauparlant has served as CEO of companies of the Sanderling portfolio, including PreciThera Inc. an early-stage company specialized in developing biologics for rare musculoskeletal diseases and SpecificiT Pharma Inc.
Is this you? Remove my profile
Loading relationship preview